First Time Loading...

Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 91.84 USD 0.05% Market Closed
Updated: Apr 30, 2024

Amedisys Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amedisys Inc
Operating Income Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Amedisys Inc
NASDAQ:AMED
Operating Income
$193.1m
CAGR 3-Years
1%
CAGR 5-Years
4%
CAGR 10-Years
36%
DaVita Inc
NYSE:DVA
Operating Income
$1.6B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
-1%
Quest Diagnostics Inc
NYSE:DGX
Operating Income
$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
2%
CAGR 10-Years
2%
CVS Health Corp
NYSE:CVS
Operating Income
$15.1B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
7%
Cigna Corp
NYSE:CI
Operating Income
$9B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Income
$1.1B
CAGR 3-Years
-34%
CAGR 5-Years
-5%
CAGR 10-Years
2%

See Also

What is Amedisys Inc's Operating Income?
Operating Income
193.1m USD

Based on the financial report for Dec 31, 2023, Amedisys Inc's Operating Income amounts to 193.1m USD.

What is Amedisys Inc's Operating Income growth rate?
Operating Income CAGR 10Y
36%

Over the last year, the Operating Income growth was 0%. The average annual Operating Income growth rates for Amedisys Inc have been 1% over the past three years , 4% over the past five years , and 36% over the past ten years .